Adverse Effects of Ivermectin Used in Egypt During COVID-19

Menoufia University200 enrolled

Overview

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH protocol that has been published in November 2020 the study will document the adverse effects of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose regimens

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Covid19 Ivermectin Poisoning Drug Toxicity Drug Side Effect

Interventions

IvermectinDRUG

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Eligibility

Sex: ALLMin age: 16 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all people used ivermectin as a treatment or as a prophylactic in covid 19 pandemic in egypt with explained dose Exclusion Criteria: \-

Locations (1)

Ahmed Mansour

Shibīn al Kawm, Menoufia, Egypt

Outcomes

Primary Outcomes

all adverse effects will be collected from people used Ivermectin in between September 2020 to December 2020

all data will be collected from retrospective manner as a retrospective study

Time frame: the data will be collected from February 2021 to march 2021

Secondary Outcomes

all data will be arranged according to time and dose manner

data for each dose will be identified together

Time frame: February to match 2021

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.